{"schema":"hottub-news/prospects/v1","item":{"id":"n_obwaxuyygw5l2ha643fa","title":"FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss","title_en":null,"url":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","outlet":"Ars Technica","published":"2026-11-10T14:43:49Z","sponsored":false,"page":"https://hottub.news/articles/n_obwaxuyygw5l2ha643fa"},"prospects":[{"name":"United States Food and Drug Administration","kind":"organization","role":"named","entity":"wikidata:Q204711","source":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","note":"In the news: FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss (Ars Technica, 2026-11-10)","reason":"Named in a headline on 2026-11-10: “FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss” (Ars Technica)","group":"Organizations","add_url":"https://crm.joinhottub.com/relationships/add#name=United%20States%20Food%20and%20Drug%20Administration&kind=organization&source=https%3A%2F%2Farstechnica.com%2Fhealth%2F2026%2F11%2Fglp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns&entity=wikidata%3AQ204711&note=In%20the%20news%3A%20FDA%20warns%20GLP-1%20drugs%20may%20pose%20risk%20of%20rare%20condition%20that%20causes%20vision%20loss%20%28Ars%20Technica%2C%202026-11-10%29","propose":{"name":"United States Food and Drug Administration","kind":"organization","reason":"Named in a headline on 2026-11-10: “FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss” (Ars Technica)","requestId":"news:n_obwaxuyygw5l2ha643fa:wikidata:Q204711:9741982a","sourceUrl":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","entity":"wikidata:Q204711"}},{"name":"Beth Mole","kind":"person","role":"reporter","company":"Ars Technica","website":"https://arstechnica.com/","source":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","note":"Wrote: FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss","reason":"Reporter at Ars Technica; wrote “FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss” on 2026-11-10","group":"Reporters","add_url":"https://crm.joinhottub.com/relationships/add#name=Beth%20Mole&company=Ars%20Technica&website=https%3A%2F%2Farstechnica.com%2F&source=https%3A%2F%2Farstechnica.com%2Fhealth%2F2026%2F11%2Fglp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns&note=Wrote%3A%20FDA%20warns%20GLP-1%20drugs%20may%20pose%20risk%20of%20rare%20condition%20that%20causes%20vision%20loss","propose":{"name":"Beth Mole","kind":"person","reason":"Reporter at Ars Technica; wrote “FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss” on 2026-11-10","requestId":"news:n_obwaxuyygw5l2ha643fa:Reporter:1bcc8eaf:e630c19c","company":"Ars Technica","website":"https://arstechnica.com/","sourceUrl":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns"}},{"name":"Ars Technica","kind":"organization","role":"outlet","website":"https://arstechnica.com/","entity":"wikidata:Q584152","source":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","note":"Published: FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss (2026-11-10)","reason":"Published “FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss” on 2026-11-10","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=Ars%20Technica&kind=organization&website=https%3A%2F%2Farstechnica.com%2F&source=https%3A%2F%2Farstechnica.com%2Fhealth%2F2026%2F11%2Fglp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns&entity=wikidata%3AQ584152&note=Published%3A%20FDA%20warns%20GLP-1%20drugs%20may%20pose%20risk%20of%20rare%20condition%20that%20causes%20vision%20loss%20%282026-11-10%29","propose":{"name":"Ars Technica","kind":"organization","reason":"Published “FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss” on 2026-11-10","requestId":"news:n_obwaxuyygw5l2ha643fa:wikidata:Q584152:07adf423","website":"https://arstechnica.com/","sourceUrl":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","entity":"wikidata:Q584152"}}],"someone_else":{"source":"https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns","note":"In the news: FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss (Ars Technica, 2026-11-10)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}